[go: up one dir, main page]

FR14C0066I2 - 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-B]OXAZOLES - Google Patents

2,3-DIHYDRO-6-NITROIMIDAZO[2,1-B]OXAZOLES

Info

Publication number
FR14C0066I2
FR14C0066I2 FR14C0066C FR14C0066C FR14C0066I2 FR 14C0066 I2 FR14C0066 I2 FR 14C0066I2 FR 14C0066 C FR14C0066 C FR 14C0066C FR 14C0066 C FR14C0066 C FR 14C0066C FR 14C0066 I2 FR14C0066 I2 FR 14C0066I2
Authority
FR
France
Prior art keywords
nitroimidazo
oxazoles
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR14C0066C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR14C0066I1 publication Critical patent/FR14C0066I1/fr
Application granted granted Critical
Publication of FR14C0066I2 publication Critical patent/FR14C0066I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR14C0066C 2002-10-11 2014-09-11 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-B]OXAZOLES Active FR14C0066I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002298259 2002-10-11
PCT/JP2003/013070 WO2004033463A1 (en) 2002-10-11 2003-10-10 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES

Publications (2)

Publication Number Publication Date
FR14C0066I1 FR14C0066I1 (en) 2014-10-17
FR14C0066I2 true FR14C0066I2 (en) 2015-05-22

Family

ID=32089299

Family Applications (1)

Application Number Title Priority Date Filing Date
FR14C0066C Active FR14C0066I2 (en) 2002-10-11 2014-09-11 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-B]OXAZOLES

Country Status (26)

Country Link
US (1) US7262212B2 (en)
EP (2) EP1555267B1 (en)
JP (1) JP4186065B2 (en)
KR (1) KR100723847B1 (en)
CN (4) CN102532162B (en)
AR (4) AR041198A1 (en)
AU (1) AU2003272979B2 (en)
BE (1) BE2014C053I2 (en)
BR (1) BRPI0314344B8 (en)
CA (1) CA2497569C (en)
CY (2) CY1113578T1 (en)
DK (1) DK1555267T3 (en)
ES (1) ES2400179T3 (en)
FR (1) FR14C0066I2 (en)
HU (1) HUS1400046I1 (en)
LU (1) LU92517I2 (en)
MX (1) MXPA05003674A (en)
MY (1) MY139244A (en)
PL (3) PL404913A1 (en)
PT (1) PT1555267E (en)
RU (1) RU2326121C3 (en)
SI (1) SI1555267T1 (en)
TW (1) TWI347946B (en)
UA (1) UA83200C2 (en)
WO (1) WO2004033463A1 (en)
ZA (1) ZA200501033B (en)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE502928T1 (en) 2000-11-01 2011-04-15 Millennium Pharm Inc NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
MXPA05002414A (en) 2002-10-15 2005-06-22 Otsuka Pharma Co Ltd 1-substituted 4-nitroimidazole compound and process for producing the same.
AU2004285811B2 (en) * 2003-10-31 2008-06-12 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis
JP4761756B2 (en) * 2003-10-31 2011-08-31 大塚製薬株式会社 2,3-Dihydroimidazo [2,1-b] oxazole compound
TWI300409B (en) 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
SI1731518T1 (en) 2004-03-31 2014-11-28 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
JP4787529B2 (en) * 2004-04-09 2011-10-05 大塚製薬株式会社 Pharmaceutical composition
JP4789966B2 (en) * 2004-04-09 2011-10-12 大塚製薬株式会社 Pharmaceutical composition
US7408066B2 (en) * 2005-06-20 2008-08-05 Schering Corproation Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
EP1906926B1 (en) * 2005-07-28 2010-12-01 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole derivatives
JP5105818B2 (en) * 2005-10-05 2012-12-26 大塚製薬株式会社 Pharmaceutical composition
TWI368509B (en) * 2005-10-05 2012-07-21 Otsuka Pharma Co Ltd Antituberculous therapeutic drugs and kit containing the same
CA2624558C (en) 2005-10-06 2011-02-22 Nippon Soda Co., Ltd. Cross-linked cyclic amine compounds and agents for pest control
TW200800268A (en) * 2005-11-04 2008-01-01 Otsuka Pharma Co Ltd Medicinal composition showing improved drug absorbability
US7750012B2 (en) 2005-12-21 2010-07-06 Decode Genetics Ehf Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation
AU2007216580B2 (en) * 2006-02-13 2012-09-27 Merck Serono Sa Sulfonamide derivatives for the treatment of bacterial infections
JP2007297305A (en) * 2006-04-28 2007-11-15 Daiso Co Ltd Method for producing n-(2,3-epoxy-2-methylpropyl)phthalimide
WO2008106128A2 (en) * 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
AR070301A1 (en) 2007-05-08 2010-03-31 Otsuka Pharma Co Ltd EPOXY COMPOUND AND METHOD TO PRODUCE THE SAME
ATE554078T1 (en) * 2007-07-26 2012-05-15 Vitae Pharmaceuticals Inc SYNTHESIS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 INHIBITORS
CL2008002384A1 (en) * 2007-08-15 2009-07-17 Glaxo Group Ltd Compounds derived from quinolinyloxypiperidine and pyrrolidine, pharmaceutical composition, pharmaceutical combination, useful for the treatment of inflammatory and / or allergic diseases of the respiratory tract.
JP2011500634A (en) * 2007-10-16 2011-01-06 グラクソ グループ リミテッド Quinoline derivatives for the treatment of inflammatory and allergic diseases
AR069207A1 (en) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc CYCLIC UREAS AS INHIBITORS OF THE 11 BETA - HIDROXI-ESTEROIDE DESHIDROGENASA 1
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (en) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
JP5730021B2 (en) * 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cycloalkyllactam derivatives as inhibitors of 11β-hydroxysteroid dehydrogenase 1
WO2009117109A1 (en) * 2008-03-18 2009-09-24 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
CN101965353B (en) * 2008-03-26 2014-12-17 丹诺医药(苏州）有限公司 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5451752B2 (en) * 2008-05-01 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
NZ588954A (en) 2008-05-01 2012-08-31 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
PL2324018T3 (en) 2008-07-25 2014-02-28 Boehringer Ingelheim Int Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP2012500260A (en) * 2008-08-18 2012-01-05 イェール・ユニヴァーシティー MIF modulator
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
WO2010143007A1 (en) * 2009-06-10 2010-12-16 Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik Method for the production of 2-halogeno-4-nitroimidazole
CN102131787B (en) * 2008-08-21 2014-12-03 诺贝尔炸药及系统技术有限责任公司 Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
UA109255C2 (en) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20120061771A (en) * 2009-04-30 2012-06-13 비타이 파마슈티컬즈, 인코포레이티드 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
JP5749263B2 (en) 2009-07-01 2015-07-15 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
US9198913B2 (en) 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
RU2540860C2 (en) * 2009-07-31 2015-02-10 Глоубал Элаенс Фор Тб Драг Дивелопмент Nitroimidazooxazine and nitroimidazooxazole analogues and use thereof
BR112012002278A2 (en) * 2009-07-31 2020-09-15 Global Alliance For Tb Drug Development nitroimidazo-oxazines and their uses in antitubercular therapy
EP2495563A4 (en) 2009-10-26 2013-04-10 Fujifilm Ri Pharma Co Ltd Diagnostic agent for infectious diseases
TW201200523A (en) 2010-01-29 2012-01-01 Otsuka Pharma Co Ltd Synthetic intermediate of oxazole compound and method for producing the same
GB201012209D0 (en) * 2010-05-31 2010-09-08 Ge Healthcare Ltd In vivo imaging agent
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
KR20130137628A (en) 2010-11-02 2013-12-17 베링거 인겔하임 인터내셔날 게엠베하 Pharmaceutical combinations for the treatment of metabolic disorders
JP5916739B2 (en) 2011-04-15 2016-05-11 大塚製薬株式会社 6,7-Dihydroimidazo [2,1-b] [1,3] oxazine compound
JP2015006994A (en) * 2011-10-28 2015-01-15 大正製薬株式会社 Dihydroimidazooxazole derivative
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
FR3000064A1 (en) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante SPIROISOXAZOLINE-LIKE COMPOUNDS WITH POTENTIALIZING ACTIVITY OF AN ANTIBIOTIC COMPOSITION AND PHARMACEUTICAL PRODUCT COMPRISING SUCH COMPOUNDS
ES2707362T3 (en) 2013-10-04 2019-04-03 Council Scient Ind Res 6-nitro-2,3-dihydroimidazo [2,1-b] oxazoles and a method of preparing them
CN103524492A (en) * 2013-10-23 2014-01-22 中国药科大学 Quinolones compound with side chain containing nitroimidazole group substitution as well as preparation and use thereof
AR101704A1 (en) 2014-08-28 2017-01-04 Otsuka Pharma Co Ltd FUSED HETEROCYCLIC COMPOUNDS
US9822126B1 (en) 2014-10-21 2017-11-21 Council Of Scientific & Industrial Research Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
CN105732659B (en) * 2014-12-12 2019-07-16 上海阳帆医药科技有限公司 Nitro glyoxaline compound and preparation method thereof and the purposes in pharmacy
CN107207532B (en) * 2015-01-29 2019-07-30 南京明德新药研发股份有限公司 Nitroimidazole derivatives against tuberculosis
WO2016158737A1 (en) * 2015-03-27 2016-10-06 大塚製薬株式会社 Method for producing 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy)piperidine or salt thereof
CN106317072B (en) * 2015-06-17 2020-03-17 盟科医药技术(上海)有限公司 Heterocyclic compounds for the treatment of mycobacterial infections and uses thereof
JP6905506B2 (en) 2016-02-26 2021-07-21 大塚製薬株式会社 Piperidine derivative
CN105859628B (en) * 2016-04-19 2018-08-07 清远职业技术学院 A kind of antimicrobial compound is to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases and its preparation method and application
JP2019521175A (en) * 2016-07-22 2019-07-25 メッドシャイン ディスカバリー インコーポレイテッド Crystal form and salt form of nitroimidazole compound and method for producing the same
SMT202100727T1 (en) * 2017-08-16 2022-01-10 Glaxosmithkline Ip Dev Ltd Novel compounds
CN112236141A (en) 2018-06-11 2021-01-15 大塚制药株式会社 Composition containing dramaani
CN109705022A (en) * 2018-12-28 2019-05-03 上海彩迩文生化科技有限公司 A kind of preparation method of aromatic amine intermediate
CN112300192B (en) * 2019-08-02 2023-08-11 南京长澳医药科技有限公司 Nitroimidazole compound, preparation method and application thereof
CN110483549B (en) * 2019-08-30 2021-03-05 沈阳药科大学 Preparation method of nitroimidazole pyran antituberculosis drug
CN110615800A (en) * 2019-10-16 2019-12-27 李丽丽 Nitroimidazole compound and preparation method and application thereof
CN112156088B (en) * 2020-10-30 2021-08-31 健民药业集团股份有限公司 Application of compound in preparation of mycobacterium tuberculosis inhibitor
CN113603706A (en) * 2021-08-04 2021-11-05 深圳市泰力生物医药有限公司 Crystal form of delamasil, active drug and pharmaceutical composition containing the crystal form
WO2024024938A1 (en) 2022-07-29 2024-02-01 大塚製薬株式会社 Delamanid-containing solid dispersion
CN115368252B (en) * 2022-09-19 2024-01-12 西北农林科技大学 A 4-aminophenol derivative and its application
CN116640106B (en) * 2023-05-11 2024-03-08 郑州大学 A kind of phenylpiperazine compound and its preparation method and application
CN119059990B (en) * 2024-11-01 2025-02-07 安徽昊帆生物有限公司 Preparation method of 1-carbamic acid tert-butyl piperazine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof

Also Published As

Publication number Publication date
PL376157A1 (en) 2005-12-27
TW200420568A (en) 2004-10-16
MY139244A (en) 2009-09-30
AU2003272979B2 (en) 2009-07-23
HUS1400046I1 (en) 2017-04-28
EP1555267A4 (en) 2010-08-18
EP2570418A3 (en) 2013-07-03
CN101172981A (en) 2008-05-07
CN102532162A (en) 2012-07-04
AR086485A2 (en) 2013-12-18
JP2004149527A (en) 2004-05-27
CN100366624C (en) 2008-02-06
PL404913A1 (en) 2013-09-30
EP2570418A2 (en) 2013-03-20
AR089950A2 (en) 2014-10-01
HK1171018A1 (en) 2013-03-15
US7262212B2 (en) 2007-08-28
KR100723847B1 (en) 2007-05-31
EP1555267A1 (en) 2005-07-20
HK1085463A1 (en) 2006-08-25
MXPA05003674A (en) 2005-06-08
AR041198A1 (en) 2005-05-04
CY2014041I1 (en) 2016-07-27
CN101255170A (en) 2008-09-03
KR20050061473A (en) 2005-06-22
JP4186065B2 (en) 2008-11-26
BE2014C053I2 (en) 2022-08-30
BRPI0314344B1 (en) 2019-11-26
RU2326121C3 (en) 2021-09-17
SI1555267T1 (en) 2013-05-31
CY1113578T1 (en) 2016-06-22
CA2497569A1 (en) 2004-04-22
RU2005114017A (en) 2006-01-20
CY2014041I2 (en) 2016-07-27
AU2003272979A1 (en) 2004-05-04
DK1555267T3 (en) 2013-02-11
FR14C0066I1 (en) 2014-10-17
CN102532162B (en) 2015-05-27
PL217919B1 (en) 2014-09-30
ZA200501033B (en) 2006-06-28
LU92517I2 (en) 2014-10-13
WO2004033463A1 (en) 2004-04-22
TWI347946B (en) 2011-09-01
US20060094767A1 (en) 2006-05-04
UA83200C2 (en) 2008-06-25
PL409525A1 (en) 2014-11-10
PT1555267E (en) 2013-01-29
CA2497569C (en) 2011-05-24
BRPI0314344B8 (en) 2021-05-25
ES2400179T3 (en) 2013-04-08
BR0314344A (en) 2005-07-12
CN1705670A (en) 2005-12-07
RU2326121C2 (en) 2008-06-10
AR091771A2 (en) 2015-02-25
EP1555267B1 (en) 2013-01-16

Similar Documents

Publication Publication Date Title
FR14C0066I2 (en) 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-B]OXAZOLES
BR0313875B1 (en) Toothbrush.
BR0313318B1 (en) Toothbrush.
DK2308855T3 (en) 2,4-Diamino
DE602004006169D1 (en) SUBSTITUTED 8'-PYRI (MI) DINYL-DIHYDROSPIRO-ÄCYCLOALKYLAMINE-PYRIMIDOE1,2A-PYRIMIDIN-6-ONDERIVATE
NO20043696L (en) Gamma-secretase
ATE326467T1 (en) IMIDAZO 1,2-AÖPYRIDINE
NO20052248D0 (en) Svivelstykkesystem.
DE60315471D1 (en) 2,5-DISUBSTITUTED 3-MERCAPOTOPANEAN
FI20020881A0 (en) The impactor,
ITMI20032170A1 (en) TAGLIACIMOSSE.
ITMI20030365A1 (en) SPINNING.
NO20051497D0 (en) Beta-laktamaseinhibitorprodrug.
NO20044405L (en) Neurotensinactive 2,3-diaryl-pyrazolidine derivatives
ITMI20030916A1 (en) HAND.
ES1052590Y (en) Kiosk-SET.
SE0301847D0 (en) Novel 3,3-Diphenylpropylamines
ES1053052Y (en) TURNING MACHINE.
ES1052831Y (en) RULETA CYLINDER.
PT9850T (en) IMPROVED DOUBLE
ITTO20020194U1 (en) STILL PERFECTED.
ES1051703Y (en) POTERA.
ES1051110Y (en) BOX-PALLET.
ES1052029Y (en) BALL-PROJECTILE.
ES1052654Y (en) CUBITERA